Kynurenine in ME/CFS

Kynurenine, also described as Tryptophan metabolite, belongs to the metabolic group of ME/CFS (ME/CFS, CFS) markers and is reported to be raised relative to healthy controls. Symptom domains tied to this marker in the source include neuroinflammation, fatigue. The evidence summarised here comes from Saito et al. 2024 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedMetabolic

Summary

Direction in ME/CFS↑ Elevated — higher than in the comparison group
CategoryMetabolic
Also described asTryptophan metabolite
Compared againstHC (healthy controls)
Associated symptomsNeuroinflammation, fatigue
Test typeBlood test (serum / plasma / whole blood)
SourceSaito et al. 2024 — doi:10.3389/fimmu.2024.1341843
Condition atlasME/CFS Biomarker Atlas

Other conditions where Kynurenine is reported

See the cross-condition hub: Kynurenine across conditions.

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Hormonal levels (inluding tryptophan metabolites) (2 registered trials use a matching outcome measure).

Clinical trials using Kynurenine as an outcome

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Related Metabolic markers in ME/CFS

Full list: ME/CFS Biomarker Atlas.

Frequently asked questions

Is Kynurenine high or low in ME/CFS?

Elevated. Studies summarised in the OSMF atlas report higher Kynurenine in ME/CFS than in healthy controls. Source: Saito et al. 2024.

What symptoms is Kynurenine associated with in ME/CFS?

The cited literature associates this marker with Neuroinflammation, fatigue. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Kynurenine?

It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Kynurenine result diagnostic of ME/CFS?

No. No single biomarker is diagnostic of ME/CFS. Kynurenine findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Kynurenine specific to ME/CFS?

No. The same marker is also reported in Long COVID in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Kynurenine in ME/CFS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/me-cfs/kynurenine.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from me-cfs.json · Browse: ME/CFS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.